The global viscosupplementation market is entering a transformative decade, with revenues expected to expand from USD 2.2 billion in 2025 to USD 3.8 billion by 2035, growing at a steady CAGR of 5.7%. Fueled by an aging global population, rising osteoarthritis cases, and growing demand for non-surgical treatment options, the market is gaining traction as a preferred therapy for joint pain management.
Request Market Research Draft Report: https://www.futuremarketinsigh....ts.com/reports/sampl
Viscosupplementation, primarily involving the injection of hyaluronic acid into joints, is increasingly recognized as a minimally invasive alternative to surgery and long-term pain medications. By 2030, the industry is projected to add USD 700 million in incremental value, reaching USD 2.9 billion, before accelerating to its final 2035 outlook.
Innovation Driving Growth